Foerster, Friedrich; Gairing, Simon Johannes; Mueller, Lukas et al.
NAFLD-driven HCC: Safety and efficacy of current and emerging treatment optionsJOURNAL OF HEPATOLOGY. Bd. 76. H. 2. 2022 S. 446-457
Huber, Yvonne; Foerster, Friedrich; Moehler, Markus et al.
New Studies at the University Medical Center Mainz on HCC and non-metastatic Colon CarcinomaGASTROENTEROLOGE. Bd. 17. H. 1. 2022 S. 57-58
Penzkofer, Lea; Mittler, Jens; Heinrich, Stefan et al.
Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver-A Single Centre StudyJOURNAL OF CLINICAL MEDICINE. Bd. 11. H. 19. 2022
Thol, Felix; Gairing, Simon Johannes; Czauderna, Carolin et al.
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancerJHEP REPORTS. Bd. 4. H. 3. 2022
Gines, Pere; Castera, Laurent; Lammert, Frank et al.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesHEPATOLOGY. Bd. 75. H. 1. 2022 S. 219-228
Labenz, Christian; Kostev, Karel; Galle, Peter Robert et al.
Prescription rates of common medications in patients with decompensated cirrhosis in GermanyZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 60. H. 02. 2022 S. 165-169
Huber, Yvonne; Schulz, Andreas; Schmidtmann, Irene et al.
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in GermanyHEPATOLOGY COMMUNICATIONS. 2022
Mettler, Esther; Fottner, Christian; Bakhshandeh, Neda et al.
Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine NeoplasiasCANCERS. Bd. 14. H. 4. 2022
Bitzer, M.; Voesch, S.; Albert, J. et al.
S3 Guideline: Diagnosis and Therapy of Biliary Carcinoma Short Version 2.00-June 2021, AWMF Register Number: 032-053OLZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 60. H. 02. 2022 S. 219-238
Bitzer, M.; Voesch, S.; Albert, J. et al.
S3-Guideline - Diagnosis and Therapy of Biliary CarcinomaZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 60. H. 02. 2022 S. E186-E227
Fottner, Christian; Sollfrank, Stefanie; Ghiasi, Mursal et al.
Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial InsulinomatosisCANCERS. Bd. 14. H. 7. 2022
Boedecker-Lips, Simone Cosima; Lautem, Anja; Runkel, Stefan et al.
Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant RecipientsPATHOGENS. Bd. 11. H. 1. 2022
Kremer, Wolfgang Maximilian; Labenz, Christian; Kuchen, Robert et al.
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre studyINTERNIST. Bd. 63. H. SUPPL 3. 2022 S. 342-343
Douglas, Raymond S.; Kahaly, George J.; Ugradar, Shoaib et al.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatmentOPHTHALMOLOGY. Bd. 129. H. 4. 2022 S. 438-449
Mueller, Lukas; Gairing, Simon Johannes; Kloeckner, Roman et al.
The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapyCANCER IMAGING. Bd. 22. H. 1. 2022
Bahr, Katharina; Simon, Perikles; Leggewie, Barbara et al.
The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea SyndromeBIOLOGY-BASEL. Bd. 11. H. 1. 2022
Ridder, Dirk Andreas; Urbansky, Lana Louisa; Witzel, Hagen Roland et al.
Transforming Growth Factor-beta Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeCANCERS. Bd. 14. H. 2. 2022
Bednarczuk, Tomasz; Brix, Thomas H.; Schima, Wolfgang et al.
2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid DysfunctionEUROPEAN THYROID JOURNAL. Bd. 10. H. 4. 2021 S. 269-284
Diana, Tanja; Ungerer, Martin; Wuster, Christian et al.
A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse modelJOURNAL OF AUTOIMMUNITY. Bd. 122. 2021
Moehler, Markus; Michel, Maurice; Stein, Alexander et al.
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerFUTURE ONCOLOGY. Bd. 17. H. 25. 2021 S. 3309-3319
Sangro, Bruno; Harding, James J.; Johnson, Matthew et al.
A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Schattenberg, Jorn M.; Pares, Albert; Kowdley, Kris V. et al.
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJOURNAL OF HEPATOLOGY. Bd. 74. H. 6. 2021 S. 1344-1354
Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad et al.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASHNEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 17. 2021 S. 1547-1558
Albrecht, K.; Lotz, J.; Frommer, L. et al.
A rapid point-of-care assay accurately measures vitamin DJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 44. H. 11. 2021 S. 2485-2492
Eslam, Mohammed; Wong, Grace Lai-Hung; Hashem, Ahmed M. et al.
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 116. H. 5. 2021 S. 984-993